2026
Generic Health rebranded itself as Lupin AU
This transition marked an important step in the evolution of our business as we more closely aligned our identity with the global parent company, Lupin.
Operating as Lupin AU allows us to better leverage our global expertise while continuing to deliver high quality affordable medicines to Australian patients.
2025
Launched the first biosimilar, Nepexto®
With the launch of etanercept, our first biosimilar, we strengthened our commitment to improving access to affordable treatment by foraying into niche therapeutic areas.
2013
Launched over-the-counter brand, Pharmacy Action
Launched to meet the growing demand for value‑driven healthcare, Pharmacy Action delivers a comprehensive range of over-the-counter medicines that address the wider consumer health needs.
2012
Generic Health acquired by Lupin Ltd.
The acquisition leveraged Lupin’s size, strength and global presence, which transformed Generic Health into a key player in the Australian generic medicines market.
Under Lupin’s umbrella, Generic Health created a sustainable platform designed for growth; expanding into key therapeutic areas and investing heavily in stakeholder relationships.
2007-2011
The era of acquisitions and partnerships
Over the years, Generic Health fostered multiple acquisitions and partnerships that strengthened and cemented its capabilities and expertise.
- 2011: Acquired marketing rights to the GOANNA brand of therapeutic creams, rubs and oils.
- 2009: Max Pharma Pty Ltd joined, expanding into specialty hospital generics.
- 2007: Acquired Bellwether Pharma Ltd, strengthening generic pharmaceutical capabilities.
2004
Generic Health Pty Ltd founded
Generic Health was created with the belief that all Australians should have access to high-quality, cost-effective medicines.
With that goal underpinning everything we do, we have transformed into one of the fastest growing pharmaceutical companies in Australia.
Lupin Memberships
APCO Membership
In 2020, Generic Health became a member of the Australian Packaging Covenant Organisation (APCO) and are committed to working towards achieving the 2025 National Packaging Targets.
As part of our commitment, Generic Health trading as Lupin AU will review all packaging used with the aim of ensuring materials used are reusable, renewable or recyclable where possible. A copy of our APCO Annual Report & Action Plan can be found here.